TY - JOUR
T1 - Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients
AU - Baker, Marshall S.
AU - Chen, Xiaojuan
AU - Rotramel, Alizah R.
AU - Nelson, Jeffrey J.
AU - Lu, Bao
AU - Gerard, Craig
AU - Kanwar, Yashpal
AU - Kaufman, Dixon B.
PY - 2003/8/1
Y1 - 2003/8/1
N2 - Background. Interaction of chemokine receptor CXCR3 with its ligand IP-10 mediates effector cell trafficking to sites of allograft rejection in murine models of whole organ allotransplantation. We hypothesized that blocking the CXCR3/IP-10 interaction would impair posttransplantation leukocyte trafficking to and delay rejection of pancreatic islet allografts. Methods. A/J strain murine islets were implanted to the kidney capsule of H-2 disparate, streptozotocin-induced diabetic wild type (WT), CXCR3 deficient (CXCR3 −/−) or IP-10 antibody-treated WT (αIP-10) C57BL/6 recipients. Representative grafts from each group were harvested at day 7. Ribonuclease protection assay was used to determine gene expression for cell markers F4/80 (macrophages), CD8 (type I T cells), CD4 (type II T cells), and CD 19 (natural killer cells), and for chemokines IP-10, MIP-1α, MIP-1β, MCP-1, and RANTES. Immunohistochemistry was used to confirm ribonuclease protection assay infiltrate data. Graft-site chemokine gene expression and cellular infiltrate were correlated with time to functional graft rejection. Results. Untreated WT recipients demonstrated heavy graft-site cell infiltrates and increased graft-site gene expression for cell markers F4/80, CD8, CD4, and CD19, and for chemokines RANTES, IP-10, and MIP-1β at day 7. In comparison with untreated WT; αIP-10-treated WT and CXCR3−/− recipients demonstrated the same degree of chemokine gene expression but less lymphocytic infiltrate. The mean length of allograft survival was 12.7 ± 3.1 days in untreated WT versus 20.2 ± 2.7 days (P <.05) for CXCR3 −/−- and 19.7 ± 2.3 days (P <.05) for α IP-10-treated WT recipients. Conclusions. CXCR3 gene deletion or αIP-10 antibody therapy modulates posttransplantation lymphocytic graft infiltration and statistically prolongs graft survival in murine islet allograft recipients.
AB - Background. Interaction of chemokine receptor CXCR3 with its ligand IP-10 mediates effector cell trafficking to sites of allograft rejection in murine models of whole organ allotransplantation. We hypothesized that blocking the CXCR3/IP-10 interaction would impair posttransplantation leukocyte trafficking to and delay rejection of pancreatic islet allografts. Methods. A/J strain murine islets were implanted to the kidney capsule of H-2 disparate, streptozotocin-induced diabetic wild type (WT), CXCR3 deficient (CXCR3 −/−) or IP-10 antibody-treated WT (αIP-10) C57BL/6 recipients. Representative grafts from each group were harvested at day 7. Ribonuclease protection assay was used to determine gene expression for cell markers F4/80 (macrophages), CD8 (type I T cells), CD4 (type II T cells), and CD 19 (natural killer cells), and for chemokines IP-10, MIP-1α, MIP-1β, MCP-1, and RANTES. Immunohistochemistry was used to confirm ribonuclease protection assay infiltrate data. Graft-site chemokine gene expression and cellular infiltrate were correlated with time to functional graft rejection. Results. Untreated WT recipients demonstrated heavy graft-site cell infiltrates and increased graft-site gene expression for cell markers F4/80, CD8, CD4, and CD19, and for chemokines RANTES, IP-10, and MIP-1β at day 7. In comparison with untreated WT; αIP-10-treated WT and CXCR3−/− recipients demonstrated the same degree of chemokine gene expression but less lymphocytic infiltrate. The mean length of allograft survival was 12.7 ± 3.1 days in untreated WT versus 20.2 ± 2.7 days (P <.05) for CXCR3 −/−- and 19.7 ± 2.3 days (P <.05) for α IP-10-treated WT recipients. Conclusions. CXCR3 gene deletion or αIP-10 antibody therapy modulates posttransplantation lymphocytic graft infiltration and statistically prolongs graft survival in murine islet allograft recipients.
UR - http://www.scopus.com/inward/record.url?scp=0041326683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0041326683&partnerID=8YFLogxK
U2 - 10.1067/msy.2003.213
DO - 10.1067/msy.2003.213
M3 - Article
C2 - 12947308
AN - SCOPUS:0041326683
SN - 0039-6060
VL - 134
SP - 126
EP - 133
JO - Surgery
JF - Surgery
IS - 2
ER -
